Arginine Deiminase (ADI), Pseudomonas Aeruginosa Recombinant
Arginine deiminase (ADI) is a potential anti-tumor biologics for the treatment of arginine-auxotrophic tumors, such as hepatocellular carcinomas and melanomas. ADI hydrolyzes arginine to citrulline and ammonia.
Product Specifications
CAS Number
9000-83-3
Shipping Conditions
Gel Pack
Storage Conditions
-20°C
Shelf Life
12 months
Frequently Asked Questions
More Discoveries
Explore Other Products
Browse additional items from our catalog